Biopharma is reshaping the healthcare industry, and smart investors are paying close attention. The healthcare sector could see major changes as artificial intelligence accelerates drug discovery, ...
IRhythm outlines $690M-$700M revenue guidance for 2025 amid Zio AT growth and primary care expansion
CEO Quentin Blackford highlighted robust revenue performance in Q1 2025, reporting $158.7 million in revenue, representing over 20% growth year-over-year. This growth was attributed to strong market ...
Gain insights into growth companies as you explore their rapid earnings growth, key characteristics, and how they stand out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback